-
Mashup Score: 8Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea - 3 year(s) ago
This case-control study evaluates the performance of the H2FPEF and HFA-PEFF algorithms to diagnose heart failure with preserved ejection fraction among ambulatory patients with dyspnea.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
Background: We’ve shown that combined caloric restriction (CR) and aerobic exercise training (AT) improve peak exercise O2 consumption (VO2peak); and quality-of-life (QOL) in older patients with obes
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
A RCT of Resistance Training Added to Caloric Restriction Plus #Aerobic Exercise Training in Obese #HFpEF Adding resistance training to #diet and #exercise program may aid adults with #obesity, HFpEF https://t.co/hsDgJBbSQi @CircHF #HeartFailure @DrMarthaGulati @DBelardoMD https://t.co/Xw7auamylN
-
-
Mashup Score: 3The EMPEROR’s New Clothes: Aren’t We Just Treating Grades of Heart Failure With Reduced Ejection Fraction? - 3 year(s) ago
Robin A.P. Weir Correspondence to: Robin A.P. Weir, MD, Cardiology Department, University Hospital Hairmyres, Eaglesham Road, Glasgow G75 8RG, Scotland, United Kingdom. Email E-mail Address: [email protected] https://orcid.org/0000-0001-9895-2795 Cardiology Department, University Hospital Hairmyres, NHS Lanarkshire, Scotland, United Kingdom. Search for more papers by this author
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OnMyMind: This paper discusses empagliflozin efficacy in patients with HF and normal EF (>60%) and queries the existence of true #HFpEF #AHAJournals https://t.co/BMuNrptNqX https://t.co/XMSUjNLXVo
-
-
Mashup Score: 3
The prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing with the aging population.1,2 However, developing tools to diagnose left ventricular diastolic dysfunction (LVDD) as the underlying mechanism for HFpEF in the older adult population is difficult due to age-related physiological changes in cardiac function.3-5 Deep Learning Patient-Similarity Framework (DeepNN)…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Developing 🔨 🔧 to diagnose LVDD as the underlying mechanism for #HFpEF in older adults is difficult due to age-related physiological changes in cardiac function. More on DeepNN for age-invariant recognition of diastolic dysfunction in elderly patients: https://t.co/mc1m7qpDg5 https://t.co/YGPSzCeXI5
-
-
Mashup Score: 2Dapagliflozin and Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction - 3 year(s) ago
This pooled analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) and Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) trials investigates the effect of dapagliflozin on specific causes of…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
#DAPA_POOLED 🔥 #dapa effect on Cause-Specific Mortality in #HeartFailure across the spectrum of #LVEF 🍀Significant ⬇️ of #CV_☠️ & of #All_cause-☠️ 🍀 Trend of ⬇️ #SCD ☠️ ✅ Confirmed different cause of ☠️ in #HFrEF vs #HFpEF @mmamas1973 @JavedButler1 https://t.co/oQ9bWVChVP https://t.co/mGH4M4Ab9I
-
-
Mashup Score: 2Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Preserved Ejection Fraction - 3 year(s) ago
This prespecified analysis of the Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) randomized clinical trial investigates if the effects of dapagliflozin on cardiovascular events vary with baseline kidney function.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
#DELIVER 🔥 #Dapa efficacy in #HFmrEF & #HFpEF across the full spectrum of renal function 🧩 Another piece of the puzzlereinforcing the recent metanalysis on #SGLT2i on kidney function @mvaduganathan @BrighamResearch @gcfmd @KardiologieHH @DrMarthaGulati https://t.co/UvhNzEFbP1 https://t.co/hOoiIWQRWt
-
-
Mashup Score: 1
In patients with heart failure with mildly reduced or preserved ejection fraction, oral dapagliflozin improved heart failure outcomes to a similar extent in three glycaemia subgroups: normoglycaemia, prediabetes, and type 2 diabetes. Moreover, the heart failure benefits of dapagliflozin seem to be consistent across a continuous glycaemic range.
Categories: Cardiologists, Latest HeadlinesTweet-
*New* from #DELIVER in @TheLancetEndo Dapagliflozin in #HFmrEF & #HFpEF ✅ Consistent benefit across glycemic spectrum ✅ Efficacious irrespective of background metformin or insulin ✅ 0 cases of serious hypoglycemia or ketoacidosis in those w/o diabetes https://t.co/B6rq1UOW3d https://t.co/5PCjanlXBX
-
-
Mashup Score: 1
Jacob B. Pierce, Zhen Li, Melissa Greiner, Steven J. Lippmann, N. Chantelle Hardy, Xian Shen, Mark Stampehl, Robert J. Mentz, Larry A. Allen, Pamela N. Peterson, Gregg C. Fonarow, Emily C. O’Brien and Stephen J. Greene Jacob B. PierceJacob B. Pierce Department of Medicine, Duke University School of Medicine, Durham, NC , Zhen LiZhen Li Department of Population Health Sciences, Duke…
Source: Circulation: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet-
⭐#AHA22 Sim Pub from @SJGreene_md et al: Adoption of Sacubitril/Valsartan Among Patients w. HFmrEF or HFpEF: #GWTGHF 📖Read more: https://t.co/6pnZvWJ3U0 #AHAJournals #CircHF @DCRINews @AHAScience #HFpEF https://t.co/mMEwwXfYJe
-
-
Mashup Score: 1
Background Obesity is a well-defined risk factor for heart failure with preserved ejection fraction (HFpEF), but it is associated with a better prognosis in patients with diagnosed HFpEF. The paradoxically poor prognosis in nonobese patients with HFpEF may be driven by a subset of high-risk patients, which suggests that the nonobese HFpEF subpopulation is heterogeneous. Methods Latent class…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
NEW: Distinct implications of #BMI in diff subgroups of nonobese patients with heart failure with preserved ejection fraction: posthoc analysis from the #TOPCAT trial - https://t.co/s7xC7rU1E2 #cardiotwitter - more from our #HFpEF Collection here https://t.co/ltiYKUWUjO https://t.co/ZSmlrc8Lxk
-
-
Mashup Score: 9Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Preserved Ejection Fraction - 3 year(s) ago
This prespecified analysis of the Dapagliflozin Evaluation to Improve the Lives of Patients With Preserved Ejection Fraction Heart Failure (DELIVER) randomized clinical trial investigates if the effects of dapagliflozin on cardiovascular events vary with baseline kidney function.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
#Dapagliflozin and Kidney Outcomes in Patients With #HeartFailure With Mildly Reduced or Preserved Ejection Fraction : A Prespecified Analysis of the #DELIVER Trial #HeartFailure #HFpEF #HFmrEF https://t.co/YP24gmTeMM @JavedButler1 @scottdsolomon @DrMarthaGulati @kidney_boy https://t.co/ZYcFXbbSNa https://t.co/ohhmVI51tx
-
@GiuseppeGalati_ @JJheart_doc @TomLuscher @AndrewJSauer @GianluSava @rudolf_deboer @DrDEliaEmilia @PSJhund @markcpetrie20 @DrCCaroli @FormigaFrancesc @Dr_Manito @CNCFCardio @lamcardio @fikkumamoto The key question here is: what constituted the gold standard diagnosis of #HFpEF? The only way to really exclude HFpEF is by #iCPET and even then it can be tricky. Most rigorous effort IMO by @yreddyhf in @JAMACardio https://t.co/kk6Bx0EB1x https://t.co/tyL2mfHY7B